EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY-NC-ND 4.0

Self-Management for Youth Living with Sickle Cell Disease (SMYLS): A study protocol for a multisite randomized controlled trial testing a behavioral, mHealth app

Shannon Phillips, Kaila Martin, Alyssa M Schlenz, Julie Kanter, Martina Mueller, Jeffery Lebensburger, Najibah Galandanci, Beng R Fuh, Chelsea Rivenbark, Ofelia A Alvarez, Rochelle F Hanson, Mohan Madisetti und 2 weitere

Contemporary Clinical Trials · 2025

DOI: 10.1016/j.cct.2025.108103 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Shannon Phillips und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, Medical University of South Carolina, 99 Jonathan Lucas St., Room 516, Charleston, SC 29425, USA. Electronic address: phillipss@m…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Self-Management, Mobile Applications. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINR NIH HHS, National Institute of Nursing Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adolescents and young adults (AYA) with sickle cell disease (SCD) encounter adverse health events during transition to adult care. While AYA with SCD face complex barriers to care, negative outcomes can be mitigated by the development of self-management behaviors. Self-Management for Youth Living with Sickle Cell Disease (SMYLS) is an application designed to improve SCD specific self-management, with promising results from feasibility studies. This paper describes the next stage of SMYLS, a multisite, hybrid type 1 effectiveness-implementation randomized controlled trial. Trial aims are to evaluate the effectiveness of the mHealth application, including the role of patient activation; assess potential for wide-scale implementation; and explore the impact of socioenvironmental and psychosocial factors on outcomes. There will be 272 AYA with SCD and their caregivers enrolled and randomized to control or intervention arm (1:1) after assessing activation level. The intervention arm will receive usual care and be encouraged to use the application daily for an initial intervention period and a later "booster" period, while the control arm will receive usual care plus a version of the application with SCD educational materials. Study aims will be evaluated using mixed methods (participant surveys at 1, 3, 6, 9, and 12 months and interviews with participants and providers/clinic administrators post-intervention). The SMYLS intervention has the potential to inform widescale adoption of a self-management intervention for AYA with SCD. The results may have broader applicability for conducting trials among youth with chronic illnesses facing similar barriers to care and for studying engagement in mHealth self-management interventions. Clinical trial registration number. NCT06035939.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellSelf-ManagementMobile ApplicationsHumansAdolescentTelemedicineYoung AdultMulticenter Studies as TopicRandomized Controlled Trials as TopicFemaleMaleQuality of Life

Stichwörter der Autor:innen

AdolescentsSelf-managementSickle cell diseaseYoung adultsmHealth

Autor:innen und Institutionen

  • College of Nursing, Medical University of South Carolina, 99 Jonathan Lucas St., Room 516, Charleston, SC 29425, USA. Electronic address: phillipss@musc.edu.
  • College of Medicine, Medical University of South Carolina, 268 Calhoun St., Charleston, SC 29425, USA. Electronic address: martikai@musc.edu.
  • Department of Pediatrics, University of Colorado School of Medicine, 13123 E 16(th) Ave, Aurora, CO 80045, USA. Electronic address: alyssa.schlenz@childrenscolorado.org.
  • Division of Hematology & Oncology, University of Alabama at Birmingham, 1720 2nd Street South, Birmingham, AL 35294, USA. Electronic address: jkanter@uabmc.edu.
  • College of Nursing, Medical University of South Carolina, 99 Jonathan Lucas St., Room 516, Charleston, SC 29425, USA. Electronic address: muellerm@musc.edu.
  • Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, 1600 7(th) Avenue S, Lowder 512, Birmingham, AL 35233, United States of America. Electronic address: jlebensburger@uabmc.edu.

Förderung

  • NINR NIH HHS
  • National Institute of Nursing Research

Zitieren

APA

Phillips, S., Martin, K., Schlenz, A. M., Kanter, J., Mueller, M., Lebensburger, J., Galandanci, N., Fuh, B. R., Rivenbark, C., Alvarez, O. A., Hanson, R. F., Madisetti, M., Prentice, M., & Kelechi, T. J. (2025). Self-Management for Youth Living with Sickle Cell Disease (SMYLS): A study protocol for a multisite randomized controlled trial testing a behavioral, mHealth app. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2025.108103

Vancouver

Phillips S, Martin K, Schlenz AM, Kanter J, Mueller M, Lebensburger J, et al. Self-Management for Youth Living with Sickle Cell Disease (SMYLS): A study protocol for a multisite randomized controlled trial testing a behavioral, mHealth app. Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2025.108103

BibTeX
@article{Phillips2025,
  author = {Phillips, Shannon and Martin, Kaila and Schlenz, Alyssa M and Kanter, Julie and Mueller, Martina and Lebensburger, Jeffery and Galandanci, Najibah and Fuh, Beng R and Rivenbark, Chelsea and Alvarez, Ofelia A and Hanson, Rochelle F and Madisetti, Mohan and Prentice, Margaret and Kelechi, Teresa J},
  title = {Self-Management for Youth Living with Sickle Cell Disease (SMYLS): A study protocol for a multisite randomized controlled trial testing a behavioral, mHealth app},
  journal = {Contemporary Clinical Trials},
  year = {2025},
  doi = {10.1016/j.cct.2025.108103}
}
Kostenlos starten →